What Scares This Analyst the Most About Keurig Green Mountain
Keurig Green Mountain has come on the scene as a specialty coffeemaker, and other companies and analysts alike took notice in recent years.
All Work
Chris Lange
How Sarepta Short Interest Is Adding to Its Gains
Analysts are beginning to flock to Sarepta after the company made news surrounding a meeting with the FDA, not to mention the enormous boost that shares are getting from short covering.
Can Another 10 Blockbuster Drugs Really Come From Johnson & Johnson in 5 Years?
Johnson & Johnson has been working on its pharmaceuticals pipeline for a while, and plans on continuing to do so.
American Eagle Outfitters Takes Flight on Earnings
American Eagle Outfitters released better-than-expected first-quarter financial results Wednesday before the markets opened.
Target Hits the Mark on Earnings
Target reported better-than-expected fiscal first-quarter financial results Wednesday before the markets opened.
Analog Devices Can’t Make Up Its Mind on Earnings
Analog Devices released better-than-expected fiscal second-quarter financial results Tuesday after the markets closed.
NYSE Gives Bitcoin a Serious Leg to Stand On
The New York Stock Exchange has announced the launching of the NYSE Bitcoin Index, the first exchange-calculated and disseminated Bitcoin index.
What to Expect From Target Earnings
courtesy of Target Corp.Target Corp. (NYSE: TGT) is scheduled to report its fiscal first-quarter results before markets open on Wednesday. The consensus estimates call for earnings per share (EPS) of $1.03 and $17.09 billion…
Is This the End of the Growth Phase for Intercept?
Investors are not too happy with Intercept Pharmaceuticals after it released the terms for its most recent clinical trial.
Why Tesla and Lithium-Ion Battery Leaders Will Dominate the Next Decade
Lux Research sees the electric vehicle (EV) opportunity as set to expand, considering the leading battery developers are driving down the prices of lithium-ion.
Can a Music Analytics Acquisition Generate More Growth at Pandora?
Pandora Media is looking to expand its horizons with its newest acquisition that gives it more insight into the analytics of streaming music online.
Will Momo Earnings Start Up Its Turnaround?
Momo reported its first-quarter financial results Tuesday before the markets opened and shares surge in the premarket.
Wal-Mart Comps Hurt the Bottom Line
Wal-Mart Stores released disappointing fiscal first-quarter financial results Tuesday before the markets opened.
Take-Two Levels Up Its Earnings
Take-Two Interactive Software reported its fiscal fourth-quarter financial results Monday after the markets closed.
What to Expect From Home Depot Earnings
Home Depot is scheduled to report its fiscal first-quarter financials Tuesday before the markets open.
Why Icahn May Be Too Ambitious in His Apple $240 Target
Carl Icahn has issued an open letter to Apple CEO Tim Cook, with a valuation path -- driven largely by buybacks -- that would theoretically make Apple worth a whopping $240 per share.
Why Analyst Changes Mind on GoPro
Oppenheimer upgrades GoPro to a Perform rating but considers its long-term negative bias on GoPro to be intact and stronger than ever.
What to Expect From Urban Outfitters Earnings
Urban Outfitters is scheduled report its fiscal first-quarter earnings Monday after the markets close.
What to Expect From Take-Two Earnings
Take-Two Interactive Software is scheduled to report its fiscal fourth-quarter financial results Monday after the markets close.
What This New Trial Means for Eleven Biotherapeutics
Eleven Biotherapeutics released its most recent clinical trial results, and its drug candidate did not meet either of its two co-primary endpoints.